Company Quick10K Filing
Gilead Sciences
10-Q 2020-03-31 Filed 2020-05-06
10-K 2019-12-31 Filed 2020-02-25
10-Q 2019-09-30 Filed 2019-11-05
10-Q 2019-06-30 Filed 2019-08-06
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-02-26
10-Q 2018-09-30 Filed 2018-11-06
10-Q 2018-06-30 Filed 2018-08-06
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-02-27
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-02-27
10-Q 2016-09-30 Filed 2016-11-07
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-06
10-K 2015-12-31 Filed 2016-02-24
10-Q 2015-09-30 Filed 2015-11-04
10-Q 2015-06-30 Filed 2015-08-05
10-Q 2015-03-31 Filed 2015-05-08
10-K 2014-12-31 Filed 2015-02-25
10-Q 2014-09-30 Filed 2014-11-05
10-Q 2014-06-30 Filed 2014-08-04
10-Q 2014-03-31 Filed 2014-05-07
10-K 2013-12-31 Filed 2014-02-25
10-Q 2013-09-30 Filed 2013-10-31
10-Q 2013-06-30 Filed 2013-08-01
10-Q 2013-03-31 Filed 2013-05-08
10-K 2012-12-31 Filed 2013-02-27
10-Q 2012-09-30 Filed 2012-11-06
10-Q 2012-06-30 Filed 2012-08-01
10-Q 2012-03-31 Filed 2012-05-04
10-K 2011-12-31 Filed 2012-02-23
10-Q 2011-09-30 Filed 2011-11-04
10-Q 2011-06-30 Filed 2011-08-05
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-02-28
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-08-09
10-Q 2010-03-31 Filed 2010-05-10
10-K 2009-12-31 Filed 2010-03-01
8-K 2020-07-30 Earnings, Exhibits
8-K 2020-06-14
8-K 2020-05-06
8-K 2020-04-30
8-K 2020-03-01
8-K 2020-02-04
8-K 2020-01-28
8-K 2019-10-24
8-K 2019-10-15
8-K 2019-08-23
8-K 2019-07-30
8-K 2019-07-17
8-K 2019-07-17
8-K 2019-07-14
8-K 2019-05-23
8-K 2019-05-08
8-K 2019-05-02
8-K 2019-04-30
8-K 2019-03-01
8-K 2019-02-04
8-K 2018-12-10
8-K 2018-10-25
8-K 2018-09-12
8-K 2018-08-06
8-K 2018-07-25
8-K 2018-07-23
8-K 2018-05-09
8-K 2018-05-01
8-K 2018-02-06
8-K 2018-01-31
8-K 2015-09-09
8-K 2015-07-28
8-K 2015-05-08
8-K 2015-04-30
8-K 2015-02-03
8-K 2015-01-22

Gilead Sciences Financials

GILD Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Amgen (AMGN) 119,768 110% 13.0 14% 59,535 48,608 17,165 18,967 8,067 10,587 138,144
Gilead Sciences (GILD) 84,019 79% 15.1 9% 61,627 39,102 22,449 17,774 5,386 6,432 96,981
Biogen Idec (BIIB) 43,857 86% 6.6 20% 27,484 13,492 14,233 12,236 5,396 6,986 45,971
Seattle Genetics (SGEN) 12,597 0% -42.8 -15% 2,098 318 801 0 -304 -290 12,404
Neurocrine Biosciences (NBIX) 9,277 80% 165.0 2% 1,180 605 676 539 21 55 9,105
Bio-Techne (TECH) 7,746 66% 42.0 5% 1,925 751 734 484 93 193 8,119
Qiagen (QGEN) 7,622 0% 5,748 3,113 0 0 0 0 8,637
Bluebird Bio (BLUE) 5,301 61% -7.0 -38% 1,892 421 54 33 -715 -704 4,946
Moderna (MRNA) 5,287 0% -13.8 -25% 1,591 339 82 0 -391 -369 5,101
Repligen (RGEN) 4,036 55% 78.3 2% 1,379 334 253 140 23 49 3,801
Autolus Therapeutics (AUTL) 3,969 0% -161.3 -8% 254 22 0 0 -21 -23 3,752
Spark Therapeutics (ONCE) 3,758 16% -14.2 -36% 704 357 70 11 -250 -250 3,548
Argenx (ARGX) 3,491 0% 578 40 0 0 0 0 3,489
Allogene Therapeutics (ALLO) 3,340 -18.1 -22% 696 76 0 0 -154 -152 2,738
China Biologic Products (CBPO) 2,933 64% 30.5 3% 2,010 165 186 119 69 85 2,594
Mesoblast (MESO) 2,543 0% 652 171 0 0 0 0 2,543
Crispr Therapeutics (CRSP) 2,445 0% -240.3 -2% 721 129 213 0 -11 -8 1,811
Acceleron Pharma (XLRN) 2,328 0% -16.2 -26% 520 55 38 0 -136 -133 2,157
Halozyme Therapeutics (HALO) 2,317 59% -78.1 -11% 370 125 203 119 -40 -29 2,267
Iovance Biotherapeutics (IOVA) 2,270 -11.5 -42% 396 41 0 0 -167 -166 1,908

Balance Sheet ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-302019-12-31
Cash1,2739371,4831,0239081,8369069099,8841,4521,6261,5511,8041,8642,2022,0112,1136,4048,7316,20910,02710,6357,41713,96512,8516,3156,4859,8098,22910,2858,71211,5087,5887,64313,23414,56917,94016,92711,2409,47411,631
Accounts Receivable1,3901,4911,4831,6701,6221,8011,9391,8671,9512,1641,7031,7661,7511,9451,8961,9722,1003,2363,4372,8504,6354,8355,3316,1055,8546,1635,7525,0754,5144,0344,4784,1223,8513,7753,5413,4653,3273,2833,3963,3153,582
Inventory1,0521,2241,3571,2731,2041,3041,3221,3381,3901,4181,6031,6171,7451,8001,9351,9462,0562,1402,0691,9101,3861,9082,0391,9881,9551,8801,8621,9001,5871,4741,4081,144801885859816814898884882922
PP&E7006966956927017047227619837838128561,3281,1261,1361,1331,4721,3031,3811,5102,0401,7651,8992,1432,6462,4312,5992,7143,6832,9223,0123,1004,2893,4153,6593,7915,1974,1164,2494,3775,924
Assets9,69910,69610,49711,45611,59312,98712,69412,64017,30319,95020,50220,96421,24022,21222,62422,46822,49728,07831,20628,84434,66438,32139,16750,63751,83947,76549,98056,60956,97757,70160,26364,66270,28365,38165,35564,30563,67562,83763,21059,14661,627
Accounts Payable8119491,0669518039821,1021,0641,2061,3391,3671,3201,3271,3561,3911,3501,2561,2351,1621,1839551,0111,5711,2391,1789451,1221,0521,206944819696814711623580790577617632713
Long-Term Debt1,1705633,4513,4854,5033,8783,8937,6069,4299,0998,7718,2247,9987,3387,3136,6369,8049,5059,41012,40412,36312,27422,22522,17822,03022,12727,07126,34626,32126,29629,26233,54229,05429,06027,31627,32226,57826,08324,58824,593
Liabilities3,3313,3543,9345,7495,7297,0416,6476,52310,56412,63712,50012,36011,93012,05911,53211,58511,12814,69015,11615,27819,23821,14122,88033,22333,30534,36734,44439,74138,09037,26037,58639,81749,84144,79043,68341,44442,28840,88640,59438,54239,102
Stockholders' Equity6,3677,3426,5625,7065,8645,9466,0476,1176,7397,3148,0028,6049,31010,15211,09210,88411,36913,38716,09113,56615,42617,18016,28717,41418,53413,39815,53616,86818,88720,44122,67724,84520,44220,59121,67222,86121,38721,95122,61620,60422,525
Income Statement ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-302019-12-31
Revenue2,0861,9271,9381,9991,9262,1372,1222,2002,2822,5662,4272,5882,5322,7672,7833,1204,9998,7516,0427,3147,5948,2448,2958,5067,7947,7767,5007,3206,5057,1416,5125,9495,0885,6485,5965,7955,2815,6855,6045,879
Cost of Revenue4404564784964745345325845816175976766346856828588139259871,0638829981,0641,0621,1938641,1291,0759571,1261,0321,2561,0011,1961,0861,5709571,0001,0351,683
Gross Profit1,6451,4721,4601,5021,4521,6031,5901,6161,7021,9491,8291,9121,8972,0832,1012,2624,1867,8265,0556,2516,7127,2467,2317,4446,6016,9126,3716,2455,5486,0155,4804,6934,0874,4524,5104,2254,3244,6854,5694,196
R&D2192312303932543062904024583964664404985245465525956336301,0456968187437571,2651,4841,1411,2089318647891,1509371,1929391,9501,0571,1604,9901,899
SG&A2662482512802963492963464433333203663744604075135486149458766458129031,0666858908319928508978791,2529979809481,1311,0301,0951,0521,204
Tax3082842591732272402371572312642802642223082943267261,0886477689071,0148807529359029518219181,0469595,9624942675651,013382535-333-788
Net Income8557127056296517467416654427126857637228197897912,2275,0942,7313,4874,3334,4974,6004,6853,5673,4973,3303,1082,7023,0732,718-3,8361,5391,8192,09931,9751,880-1,1652,696
Cash Flow ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-302019-12-31
Cash Operating6716997397258219438979784531,2917457066729537537271,5684,1854,0443,0215,7015,6584,0964,8743,9134,9404,3303,4862,9253,5262,6942,7532,2701,5732,2122,3451,4442,2212,8992,580
Cash Investing-1,069933-1,394-408-300-470-804,440-10,743-635-51850-407-55-8216-161-487-770-405-2,299-3,552-4,186-2,438-2,109-3,284-3,917-2,675307-4,246-2,114-10,0164,3545,2412,0252,735-111-6,042-2,095431
Cash Financing16-1,166270-460485-1,372-8763,5271,856-475-308-510-199-558-942-8452,884-1,372-5,7711,234-2,722-5,3416,644-3,544-8,396-1,5162,860-2,295-1,244-8802,1703,347-6,595-1,152-2,901-1,670-2,366-1,857-2,515-896